Literature DB >> 6798978

Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis.

R Wernick, J J LoSpalluto, C W Fink, M Ziff.   

Abstract

In this report, solid phase radioimmunoassays that specifically measure IgG rheumatoid factor (RF) and IgM RF in absolute concentrations are described. Polyclonal RF preparations were utilized as standards, and as little as 40 ng/ml of IgG RF and I ng/ml of IgM RF were detected. The IgG RF concentration of 26 seropositive rheumatoid sera was 439 +/ 755 micrograms/ml (mean +/- 1 SD), a level 107 times that of normal controls (P less than 0.001). In contrast, levels for 49 children with juvenile rheumatoid arthritis (JRA) were 6.1 +/- 3.7 micrograms/ml for those with a polyarticular onset (JRA-Po), and 27.3 +/- 113 micrograms/ml for the pauciarticular group (JRA-Pa), and 12.6 +/- 20.7 micrograms/ml for the group with a systemic onset (JRA-S). None of these values differed significantly from the value of 6.0 +/- 3.9 micrograms/ml measured in a juvenile control group. The IgM RF level in adult rheumatoid arthritis (RA) of 175 +/- 221 micrograms/ml was also significantly elevated compared to controls (P less than 0.001). In JRA, however, mean levels of 1.4 +/- 2.0 micrograms/ml (JRA-Po), 2.8 +/- 8.3 micrograms/ml (JRA-Pa), and 1.1 +/- 0.7 micrograms /ml (JRA-S) were not elevated significantly above the value of 1.2 +/-1.2 micrograms/ml measured in the juvenile control group. Hidden IgM RF was not found in 9 JRA sera tested. These marked differences in RF levels provide another indication that adult RA and JRA are distinct diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798978     DOI: 10.1002/art.1780241208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.

Authors:  T Tuomi; K Aho; T Palosuo; K Kaarela; R von Essen; H Isomäki; M Leirisalo-Repo; S Sarna
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

2.  IgM rheumatoid factor in congenital syphilis: associations with clinical and laboratory findings.

Authors:  M P Meyer; D W Beatty
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  Detection of autoimmunoreactive antibodies against cartilage cell surface proteins in the blood of rheumatic patients.

Authors:  J Mollenhauer; K Brune
Journal:  Agents Actions       Date:  1988-02

4.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

5.  Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis.

Authors:  A Aggarwal; S Dabadghao; S Naik; R Misra
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.

Authors:  S Uwatoko; M Mannik
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

8.  Seronegative rheumatoid arthritis, rheumatoid factor cross reactive idiotype expression, and hidden rheumatoid factors.

Authors:  V R Bonagura; J F Wedgwood; N Agostino; L Hatam; L Mendez; I Jaffe; B Pernis
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

9.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors.

Authors:  A Spadaro; V Riccieri; A Sili Scavalli; E Taccari; A Zoppini
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.